Metformin restores crizotinib sensitivity in crizotinib-resistant human lung cancer cells through inhibition of IGF1-R signaling pathway

AIM: Despite the impressive efficacy of crizotinib for the treatment of ALK-positive non-small cell lung cancer, patients invariably develop therapeutic resistance. Suppression of the IGF-1R signaling pathway may abrogate this acquired mechanism of drug resistance to crizotinib. Metformin, a widely...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Li, Wang, Yubo, Peng, Tao, Zhang, Kejun, Lin, Caiyu, Han, Rui, Lu, Conghua, He, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085167/
https://www.ncbi.nlm.nih.gov/pubmed/27144340
http://dx.doi.org/10.18632/oncotarget.9120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085167/
https://www.ncbi.nlm.nih.gov/pubmed/27144340
http://dx.doi.org/10.18632/oncotarget.9120

Ejemplares similares